Deng‐Yn Lin

4.7k citations
60 papers · 4k · 1 hit paper · h-index 27

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver physiology and pathology
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 16
    • Hepatitis C virus research 13
    • Liver Disease and Transplantation 3
    • Hepatitis Viruses Studies and Epidemiology 2
    • Liver physiology and pathology 2
    • Hepatitis B Virus Studies 22
    • Liver Disease Diagnosis and Treatment 3

Deng‐Yn Lin

60 papers receiving 3.7k citations

Deng‐Yn Lin's Hit Papers

Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study 2013 · 517 citations
5170+4+8Years since publication100200300400500

Peers

Deng‐Yn Lin
Comparison fields: 5 of 92
  • Hepatology 1.8k
  • Epidemiology 1.7k
  • Surgery 260
  • Pulmonary and Respiratory Medicine 176
  • Oncology 83
Replace Masashi Unoura with:
Masashi Unoura Japan
Onofrio Giuseppe Manghisi Italy
Shi‐Ming Lin Taiwan
Federico Tremolada Italy
John Boitnott United States
Riccardo Volpes Italy
Andrej Potthoff Germany
Giuseppe Malizia Italy
P. Del Poggio Italy
Paolo Fabris Italy
Deng‐Yn Lin relative to Masashi Unoura Japan Masashi Unoura's profile →
Citations per field
00.5×2×3×4×4.9×
Masashi Unoura · 1×
Citations per year

Countries citing papers authored by Deng‐Yn Lin

Since Specialization
Citations

This map shows the geographic impact of Deng‐Yn Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deng‐Yn Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deng‐Yn Lin more than expected).

Fields of papers citing papers by Deng‐Yn Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deng‐Yn Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deng‐Yn Lin. The network helps show where Deng‐Yn Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Deng‐Yn Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deng‐Yn Lin Line = papers co-authored together Deng‐Yn Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
Hit paper breakdown →
2013517
2 1983294
3 1986279
4 1997259
5 1988251
6
Eosinophilic gastroenteritis: 10 years experience.
1993176
7 1999168
8 1993158
9 1997149
10 1989146
11 2009143
12 1994121
13 2004115
14 1994101
15 200793
16 198481
17 198480
18 201266
19 198356
20 200340

About Deng‐Yn Lin

Deng‐Yn Lin is a scholar working on Hepatology, Epidemiology, Pulmonary and Respiratory Medicine, Surgery and Critical Care and Intensive Care Medicine, having authored 60 papers that have together received 4k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (22 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Hepatitis C virus research (13 papers), Gallbladder and Bile Duct Disorders (6 papers), Liver Disease Diagnosis and Treatment (3 papers), Liver Disease and Transplantation (3 papers), Hepatitis Viruses Studies and Epidemiology (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Hepatology (1.8k citations), Epidemiology (1.7k citations), Surgery (260 citations), Pulmonary and Respiratory Medicine (176 citations) and Oncology (83 citations). Deng‐Yn Lin has collaborated with scholars based in Taiwan, United States and Spain. Frequent co-authors include Yun‐Fan Liaw, Chia‐Ming Chu, I‐Shyan Sheen, Dar‐In Tai, Huang Mj, Chi‐Sin Changchien, Tong‐Jong Chen, Shi‐Ming Lin, Shi‐Ming Lin and Chung‐Ming Chu. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Hepatology, Gastroenterology, American Journal of Tropical Medicine and Hygiene and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact